Skip to content

Three Year Outcomes After Shoulder Arthroplasty

Evaluating Three-Year Outcomes For Total Versus Reverse Shoulder Arthroplasty

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07815535
Enrollment
300
Registered
2026-09-11
Start date
2026-09-01
Completion date
2028-08-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis Shoulder, Arthroplasty, Replacement, Shoulder, Rotator Cuff Arthropathy

Keywords

anatomic total shoulder arthroplasty, reverse total shoulder arthroplasty, shoulder replacement, patient-reported outcomes, preoperative planning, implant selection, shoulder prosthesis

Brief summary

The purpose of this multicenter observational cohort study is to evaluate three-year outcomes in adults who underwent anatomic or reverse total shoulder arthroplasty using a contemporary shoulder implant system. The main questions it aims to answer are: Are three-year patient-reported outcomes after anatomic total shoulder arthroplasty comparable to those after reverse total shoulder arthroplasty? How often do the implants used during surgery differ from the preoperative three-dimensional (3D) surgical plan, and are these differences associated with patient outcomes, complications, or revision surgery? Researchers will compare patient-reported outcomes, function, complications, and revision rates between patients who underwent anatomic and reverse total shoulder arthroplasty. Researchers will review participant existing medical records and surgical information. Participants whose two- or three-year outcome measures are not available may be asked to complete a one-time questionnaire by telephone or secure electronic survey. No treatments or additional clinical procedures will be performed as part of this study.

Detailed description

Contemporary shoulder arthroplasty systems incorporate modular components, updated implant geometry, three-dimensional (3D)-printed technology, and preoperative 3D surgical planning to support patient-specific implant selection and intraoperative decision-making. Although these features are intended to improve procedural efficiency and flexibility, multicenter evidence regarding their clinical performance and associated patient outcomes remains limited. This multicenter observational cohort study will evaluate patients who underwent primary anatomic total shoulder arthroplasty (aTSA) or reverse total shoulder arthroplasty (rTSA) using a single contemporary shoulder arthroplasty platform between 2020 and 2024. The study will combine retrospective review of existing clinical data with prospective collection of missing two- or three-year patient-reported outcome measures at a single follow-up time point. No investigational treatment, study-directed procedure, or alteration to routine clinical care will occur. Existing electronic medical records, operative reports, imaging, preoperative planning files, implant information, and patient-reported outcome databases will be retrospectively reviewed. Data collected will include demographic and clinical characteristics, surgical and implant details, preoperative planning parameters, postoperative function, patient-reported outcomes, complications, readmissions, reoperations, and revisions. When two- or three-year patient-reported outcomes are not available through routine clinical follow-up, participants may be contacted to complete a one-time validated questionnaire by telephone or secure electronic survey. The primary analysis will evaluate whether three-year outcomes after aTSA are non-inferior to those after rTSA using the American Shoulder and Elbow Surgeons score and a prespecified non-inferiority margin of 9 points. Additional analyses will compare functional outcomes, complications, and revision rates between the two procedure groups. Among patients with available preoperative 3D planning data, the study will also evaluate agreement between the planned and implanted glenoid and humeral components. Investigators will characterize the frequency and types of intraoperative deviations from the surgical plan and assess whether these deviations are associated with postoperative outcomes, complications, patient satisfaction, or revision surgery. The target sample size is up to 300 participants, with approximately 150 participants in each procedure group.

Interventions

None listed

Sponsors

Vani Sabesan
Lead SponsorOTHER
DePuy Synthes
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary shoulder arthroplasty * Age \>18 years at the time of surgery * At least 2 years from the date of surgery

Exclusion criteria

* Revision shoulder arthroplasty * Acute fracture cases * Inability to obtain consent for outcome collection

Design outcomes

Primary

MeasureTime frameDescription
American Shoulder and Elbow Surgeons (ASES) ScoreThree Years PostoperativelyThe ASES score is a patient-reported measure of shoulder pain and function scored from 0 to 100, with higher scores indicating better outcomes. Three-year ASES scores will be compared between patients who underwent anatomic and reverse total shoulder arthroplasty.
ASES ScoreOne Year, Two Years PostoperativelyThe ASES score is a patient-reported measure of shoulder pain and function scored from 0 to 100, with higher scores indicating better outcomes. Three-year ASES scores will be compared between patients who underwent anatomic and reverse total shoulder arthroplasty.

Secondary

MeasureTime frameDescription
Simple Shoulder Test scoreOne Year, Two Years, and Three Years PostoperativelyThe Simple Shoulder Test is a 12-item patient-reported assessment of shoulder function. Scores range from 0 to 12, with higher scores indicating better shoulder function.
Single Assessment Numeric Evaluation scoreOne Year, Two Years, Three Years PostoperativelyParticipants rate their shoulder function as a percentage of normal from 0 to 100, with higher scores indicating better perceived shoulder function.
Constant-Murley scoreOne Year, Two Years, Three Years PostoperativelyThe Constant-Murley score evaluates shoulder pain, activities of daily living, range of motion, and strength. Scores range from 0 to 100, with higher scores indicating better shoulder function.
PENN Shoulder ScoreOne Year, Two Years, Three Years PostoperativelyThe Penn Shoulder Score evaluates shoulder pain, satisfaction, and function. Scores range from 0 to 100, with higher scores indicating better outcomes.
University of California Los Angeles Shoulder ScoreOne Year, Two Years, Three Years PostoperativelyThe UCLA Shoulder Score evaluates pain, function, active forward flexion, strength, and patient satisfaction. Scores range from 0 to 35, with higher scores indicating better outcomes.
Shoulder Pain and Disability IndexOne Year, Two Years, Three Years PostoperativelyThe SPADI evaluates shoulder pain and disability. Scores range from 0 to 100, with higher scores indicating greater pain and disability.
Disabilities of the Arm, Shoulder and Hand ScoreOne Year, Two Years, Three Years PostoperativelyThe DASH evaluates symptoms and difficulty performing upper-extremity activities. Scores range from 0 to 100, with higher scores indicating greater disability.
Western Ontario Osteoarthritis of the Shoulder IndexOne Year, Two Years, Three Years PostoperativelyThe WOOS evaluates shoulder-related physical symptoms, sports and recreation, work, and emotional function. Scores will be converted to a percentage from 0 to 100, with higher normalized scores indicating better shoulder-related quality of life.
Short Form-12 Outcome ScoreOne Year, Two Years, Three Years PostoperativelyThe SF-12 evaluates general health-related quality of life and produces physical and mental component summary scores. Higher scores indicate better health-related quality of life.
Shoulder Range of MotionOne, Two, Three Years PostoperativelyShoulder forward flexion, abduction, external rotation, and internal rotation will be obtained from available clinical records. Forward flexion, abduction, and external rotation will be measured in degrees, and each motion will be analyzed separately.
Postoperative ComplicationsFrom date of surgery to time of data abstractionThe number and percentage of participants experiencing postoperative complications, including infection, dislocation or instability, scapular notching, acromial stress fracture, implant failure, or rotator cuff failure, will be assessed through review of existing clinical records.
Revision Shoulder SurgeryFrom date of surgery through time of study completion, an average of three yearsThe number and percentage of participants undergoing revision shoulder arthroplasty or another reoperation involving the operative shoulder will be assessed through review of existing clinical records.
Concordance between planned and implanted componentsDate of Index SurgeryAmong participants with available preoperative three-dimensional planning data, the proportion of cases in which the planned glenoid and humeral component characteristics match the components implanted during surgery will be determined. The number and percentage of cases with one or more deviations from the preoperative surgical plan will be assessed.

Countries

United States

Contacts

CONTACTVani J Sabesan, MD
sabes001@gmail.com754-233-3658

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026